The state of Idaho currently has 1 active clinical trials seeking participants for NASH - Nonalcoholic Steatohepatitis research studies. These trials are conducted in various cities, including Boise, Meridian, Idaho Falls and Nampa.
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )
This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3
18 years and above
Trial Updated:
Locations: Grand Teton Research Group, PLLC, Idaho Falls, Idaho
Conditions: NASH - Nonalcoholic Steatohepatitis